Ether

Ether

SCHEMBL437946

CC(C)OC(C)C.CCOCC

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL9793363 1.00 LMNA (0.37) LMNAALDH1A1THRB
Ether SCHEMBL8431870 0.94 ALDH1A1 (0.36) LMNAALDH1A1
Ether SCHEMBL15135184 0.91 MAPK1 (0.36) LMNA
Ether SCHEMBL5404357 0.91 TSHR (0.36) LMNAALDH1A1
Ether SCHEMBL1325841 0.91 ALDH1A1 (0.41) LMNAALDH1A1
Ether SCHEMBL11876258 0.88 ALDH1A1 (0.46) LMNAALDH1A1
Hexane SCHEMBL515233 0.88 OPRM1 (0.42) LMNATHRB
SCHEMBL29239907 0.84 ALDH1A1 (0.41) LMNAALDH1A1THRB
Ether SCHEMBL9122015 0.82 TSHR (0.46) THRB
Ether SCHEMBL7738174 0.81 LMNA (0.44) LMNAALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602914-B Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2021-09-24 CN claimed
EP-3416992-B1 PROCESS FOR PREPARING HIGH-REACTIVITY ISOBUTENE HOMO- OR COPOLYMERS BASF SE (DE) 2020-04-15 EP claimed
EP-3416992-A1 PROCESS FOR PREPARING HIGH-REACTIVITY ISOBUTENE HOMO- OR COPOLYMERS BASF SE (DE) 2018-12-26 EP claimed
CN-108602914-A Method for producing highly reactive isobutene homo-or copolymers 巴斯夫欧洲公司 2018-09-28 CN claimed
WO-2017140603-A1 PROCESS FOR PREPARING HIGH-REACTIVITY ISOBUTENE HOMO- OR COPOLYMERS BASF SE (DE) 2017-08-24 WO claimed
CN-103360291-B With producing the method that high concentration TGA prepared by the O-alkyl-N-alkyl sulfide tail washings by carbamate 青岛联拓化工有限公司 2016-12-07 CN claimed
CN-105859770-A Method of synthesizing alkyl phosphate 云南云天化以化磷业研究技术有限公司 2016-08-17 CN claimed
US-20030135041-A1 Synthesis of ceftiofur intermediate ORCHID CHEMICALS & PHARMACEUTICALS LIMITED, INDIA (IN) 2003-07-17 US claimed
US-6023005-A TOTALLY REGENERATING ONLY A PORTION OF THE TOTAL REACTION VOLUME OF CATALYST AND MIXING THE REGENERATED PORTION WITH THE UNREGENERATED TOTAL REACTION VOLUME OF CATALYST. EXXON CHEMICALS PATENTS INC. (US) 2000-02-08 US claimed
EP-0667337-B1 Method for preparing fluoroanilines CLARIANT GMBH (DE) 1998-01-21 EP claimed
EP-0667337-A1 Method for preparing fluoroanilines HOECHST AKTIENGESELLSCHAFT (DE) 1995-08-16 EP claimed
CN-113045476-B Monosubstituted or disubstituted indole derivatives as dengue virus replication inhibitors 杨森制药公司 2024-07-16 CN disclosed
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO., LTD. (JP) 2024-06-06 US disclosed
WO-2023232613-A1 PROCESS FOR MANUFACTURING OF HIGHER FUNCTIONAL POLYISOBUTENES BASF SE (DE) 2023-12-07 WO disclosed
CN-113698514-B Process for preparing highly reactive isobutylene homo-or copolymers 巴斯夫欧洲公司 2023-11-10 CN disclosed
US-4035392-A Prostanoic acid intermediate CARLO ERBA S.P.A. (IT) 1977-07-12 US disclosed
US-4021477-A 14-Chloro prostadienoic acid compounds CARLO-ERBA S.P.A. (IT) 1977-05-03 US disclosed
US-3989724-A Tetrahydropyran-2-ols HOFFMANN-LA ROCHE INC. (US) 1976-11-02 US disclosed
US-3944577-A Novel pregnane-21-oic acid derivatives SCHERING AKTIENGESELLSCHAFT (DT) 1976-03-16 US disclosed
US-3935254-A 5C-PROSTEN-13-YNOIC ACIDS CARLO ERBA S.P.A. (IT) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030135041-A1 Synthesis of ceftiofur intermediate COASY, ACACA, BCAT1 LMNA 3789/4885ALDH1A1 215/4885THRB 2228/4885
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG PREP, UNG, DPP4 LMNA 1238/4885ALDH1A1 1564/4885THRB 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.